Dharti Proteins CIRP Annual Report FY25 Net Loss

Dharti Proteins submitted its delayed 31st Annual Report for FY 2024-25, filed under the Corporate Insolvency Resolution Process (CIRP) overseen by Resolution Professional Amrish Gandhi.
The company reported nil revenue from operations and a net loss of ₹0.66 lakh, with negative equity of ₹1026.79 lakh and significant outstanding doubtful loans of ₹150.46 lakh.
Multiple severe compliance failures were disclosed, including non-payment of exchange fees, suspended listing, and violations of SEBI LODR, Companies Act, and MSMED Act provisions.
The statutory auditor issued a qualified opinion highlighting going concern risks, lack of internal controls, and inability to verify MSME creditor status or recoverability of assets.